---
title: "Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial"
date: "2023-10-06T13:51:36.000Z"
publishedDate: "6 octobre 2023"
summary: "Artivion has announced presentation of interim results from the Ascyrus medical dissection stent (AMDS) PERSEVERE clinical trial in a late-breaking science session at the 37th European Association for Cardio-Thoracic Surgery (EACTS) annual meeting (4–7 October, Vienna, Austria). Fernando Fleischman (Keck Hospital of the University of Southern California, Los Angeles, USA) delivered data from the PERSEVERE US [&#8230;] The post Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/artivion-announces-meaningful-all-cause-mortality-reduction-in-amds-persevere-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-10-06-artivion-announces-meaningful-all-cause-mortality-reduction-in-amds-persevere-trial"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/10/Artivion-logo-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/artivion-announces-meaningful-all-cause-mortality-reduction-in-amds-persevere-trial/"
---

![Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial](https://interventionalnews.com/wp-content/uploads/sites/13/2023/10/Artivion-logo-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/artivion-announces-meaningful-all-cause-mortality-reduction-in-amds-persevere-trial/*

## L’essentiel

Artivion has announced presentation of interim results from the Ascyrus medical dissection stent (AMDS) PERSEVERE clinical trial in a late-breaking science session at the 37th European Association for Cardio-Thoracic Surgery (EACTS) annual meeting (4–7 October, Vienna, Austria). Fernando Fleischman (Keck Hospital of the University of Southern California, Los Angeles, USA) delivered data from the PERSEVERE US [&#8230;] The post Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial appeared first on Interventional News .

## Lien source

https://interventionalnews.com/artivion-announces-meaningful-all-cause-mortality-reduction-in-amds-persevere-trial/
